Company profile · Biotech & medical
Oneness Biotech
合一生技股份有限公司 · 4743
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Oneness Biotech develops new drugs and produces the Fespixon cream, which is a botanical new drug for treating diabetic foot ulcers, as well as wound care medical devices.[1]
The company also operates an animal center that provides preclinical pharmacology and toxicology evaluation services for new drug development.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$11m | +154.7% | +97.2% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$112m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | ONENESS BIOTECH CO., LTD. |
|---|---|
| Chinese name | 合一生技股份有限公司 |
| Stock code | 4743 (TPEx) |
| Industry | Biotech & medical |
| Founded | 02 Jun 2008 |
| Listed | 23 Sep 2011 |
| Paid-in capital | NT$4.8bn |
| Chairman | 郭憲壽 |
| President | 王月汝 |
| Headquarters | 35F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City 100 Taipei, Taiwan |
| Website | http://www.onenessbio.com |
| Official business description | 新藥開發 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 合一生技股份有限公司 · mops · retrieved 04 Nov 2026
- 動物中心 – 合一生技股份有限公司 · website · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list